<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-27E3KOYE</identifier><date>2023</date><creator>Lovšin, Nika</creator><creator>Srpčič, Anja</creator><relation>documents/doc/2/URN_NBN_SI_doc-27E3KOYE_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-27E3KOYE_001.txt</relation><format format_type="issue">3</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 205-214</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">160756739</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-27E3KOYE</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">CRISPR/Cas9</subject><subject language_type_id="slv">Genetski inženiring</subject><subject language_type_id="slv">genetsko urejanje</subject><subject language_type_id="slv">genska terapija</subject><subject language_type_id="slv">Imunski odziv</subject><subject language_type_id="slv">izbijanje genov</subject><title>Sistem CRISPR/Cas9 in njegova uporaba v genetskem inženirstvu</title><title>The CRISPR/Cas9 system and its applications in genetic engineering</title></Record>